RXMEDS.STORE
@rxmeds_store • 3,508 subscribers
🏥 Licensed Pharmacy | Global Medicines 💊 Ivermectin· Fenbendazole· HCQ· Mebendazole 🔬 Pharma-Grade | Lab-Verified 🌐 Worldwide Shipping | 24/7 Support
Videos
🚨 DR. WILLIAM MAKIS MD CALLS THIS THE MOST IMPORTANT IVERMECTIN CANCER GRAPH HE'S EVER CREATED After reviewing hundreds of studies, case reports, and patient outcomes, Dr. William Makis MD says one question keeps coming up: ❓"What dose of Ivermectin are people actually using in cancer protocols?" His answer is surprisingly simple. 💊 For most cancers, his suggested starting point is: 1 mg/kg of Ivermectin per day 📊 THE FOUR IVERMECTIN DOSING LEVELS DR. MAKIS DISCUSSES MOST OFTEN 🔹 0.2 mg/kg daily Lower-dose protocols discussed in some case reports and published reports. 🔹 1.0 mg/kg daily Dr. Makis' typical starting point for most cancers. 🔹 2.0 mg/kg daily Discussed for highly aggressive cancers, including some brain cancers. 🔹 2.5 mg/kg daily The highest dosing level discussed in certain case reports. According to Dr. Makis, some of the most widely discussed case reports involve higher dosing strategies. And that's where the conversation gets interesting. Because this isn't being discussed for just one type of cancer. Researchers have investigated Ivermectin in: ✅ Breast Cancer ✅ Colon Cancer ✅ Lung Cancer ✅ Pancreatic Cancer ✅ Kidney Cancer ✅ Gastric Cancer ✅ Prostate Cancer ✅ Brain Cancer ✅ Leukemia And many others. Dr. Makis frequently points to reports involving significant changes in tumor markers, imaging results, and patient outcomes that continue driving interest in repurposed medicines. He also highlights something many people overlook: ✅ Off patent ✅ Generic ✅ Low cost ✅ Studied for decades Yet despite the growing number of publications and case reports, mainstream oncology rarely discusses it. That's why the debate keeps growing. Not because everyone agrees. Because patients keep sharing stories. Doctors keep debating. Researchers keep publishing. And people keep asking questions. Because if the answer were obvious... The conversation would've ended years ago. Instead, it's getting bigger. 📌 Save this chart. You'll want it later. 🔄 Repost so others can review the information for themselves. 💬 Have you been following Dr. William Makis MD's work on Ivermectin and cancer? 💊 Researching Ivermectin? Explore RXMEDS.STORE. #Ivermectin #CancerResearch #MakisMD #RepurposedDrugs
RXMEDS.STORE48,288 görüntüleme • 23 gün önce
🚨 DR. WILLIAM MAKIS REVEALED THE IVERMECTIN DOSING STRATEGY HE'S USING IN CANCER PATIENTS. HERE'S WHAT HE'S SEEING. In a recent discussion, Dr. William Makis was asked a question many cancer patients are now researching: 📌 How does he use Ivermectin in cancer protocols? His answer surprised a lot of people. For most intermediate to high-grade cancers, Dr. Makis said his typical starting dose is: 💊 1 mg/kg per day For a 60 kg (132 lb) person, that's approximately: 📊 60mg daily According to him, that's roughly 5 times higher than the dose commonly used for parasitic infections. For lower-grade cancers, he often starts lower: 💊 0.5 mg/kg per day Examples discussed included: • Chronic Lymphocytic Leukemia (CLL) • Multiple Myeloma For a 60 kg person, that would be about: 📊 30mg daily And unlike many protocols circulating online, he noted that the dosing is typically: 📅 7 days per week But the dosage wasn't the part that got my attention. The timeline was. According to Dr. Makis, some patients may begin seeing changes in cancer markers within: ⏳ 3 to 4 weeks He specifically mentioned markers such as: 📉 PSA 📉 CEA 📉 CA-125 📉 Other cancer-related markers He explained that these markers can sometimes provide an early indication that something is changing before tumors physically shrink. Then come the scans. According to his experience: 📊 PET scans may begin showing reduced cancer activity within about a month. 📊 Physical tumor shrinkage often becomes visible after roughly 2 to 3 months on PET-CT, CT, or MRI imaging. That's why he generally recommends giving a protocol: ⏳ A full 3 months Before evaluating whether a meaningful response is occurring. But perhaps the most surprising statement came near the end. Dr. Makis said the best results he has personally seen were not necessarily from Ivermectin alone. According to him, some of the most dramatic responses occurred when patients combined: 💊 Ivermectin PLUS 💊 Chemotherapy That observation is likely to spark debate from every side of the conversation. Whether you agree with his conclusions or not, one thing is clear: More patients are reading studies. More doctors are discussing repurposed medicines. And more people are asking questions that weren't being asked a few years ago. That's why conversations around Ivermectin continue to grow across cancer communities worldwide. 🌐 Looking for Ivermectin, Fenbendazole, or Mebendazole? Explore RXMEDS.STORE. #Ivermectin #WilliamMakis #CancerResearch #CancerProtocol #RepurposedDrugs
RXMEDS.STORE36,776 görüntüleme • 29 gün önce
🚨 STAGE 4 BREAST CANCER. HOSPICE CARE. EIGHT MONTHS LATER, THE PET SCAN SHOCKED EVERYONE. A 33-year-old woman was facing a devastating diagnosis. Her breast cancer had returned. And this time it had spread. 📌 Liver 📌 Lungs 📌 Spine 📌 Pelvis 📌 Multiple vertebrae 📌 Bones A liver biopsy confirmed metastatic breast cancer. MRI scans showed cancer throughout her spine and skeletal system. PET scans revealed multiple hypermetabolic lung and bone lesions. The disease was widespread. By late 2021, she declined further conventional chemotherapy and was placed under hospice care. For many patients, that's where the story ends. But in November 2021, she began taking 222mg of Fenbendazole daily. At the start: • Cancer was confirmed in her liver • Cancer was confirmed in her bones • Multiple lung lesions were present • Tumor marker CA27.29 measured 316 Over the next several months, she continued taking 222mg of Fenbendazole daily. Then something remarkable happened. ✅ Liver enzymes returned to normal ✅ Tumor marker CA27.29 dropped from 316 to 36.6 ✅ Pain from spinal metastases improved And then came the PET scan. In April 2022, follow-up imaging reportedly showed no abnormal metabolic activity indicative of cancer. Think about that. The previous scans had shown active disease in the liver, lungs, spine, pelvis, and bones. Months later, the PET scan reportedly found no evidence of abnormal cancer activity. Cases like this are why Fenbendazole continues to attract attention around the world. Not because of opinions. Because people are looking at scans. Looking at lab results. Looking at outcomes. And deciding for themselves what questions deserve answers. 💊 Looking for Fenbendazole, Ivermectin, or Mebendazole? Explore RXMEDS.STORE. #Fenbendazole #BreastCancer #CancerResearch #RepurposedDrugs #Oncology #RxMeds
RXMEDS.STORE16,476 görüntüleme • 1 ay önce
🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds
RXMEDS.STORE16,612 görüntüleme • 1 ay önce
Daha fazla içerik yok.